- Home
- HBIO
as 07-26-2024 4:00pm EST
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.
| Founded: | 1901 | Country: | United States |
| Employees: | N/A | City: | HOLLISTON |
| Market Cap: | 118.1M | IPO Year: | 2000 |
| Target Price: | N/A | AVG Volume (30 days): | 175.3K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.20 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.70 - $5.56 | Next Earning Date: | 08-06-2024 |
| Revenue: | $106,787,000 | Revenue Growth: | -6.76% |
| Revenue Growth (this year): | 1.73% | Revenue Growth (next year): | 10.81% |
Stock Insider Trading Activity of Harvard Bioscience Inc. (HBIO)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Green James W | HBIO | Chief Executive Officer | Jun 13 '24 | Buy | $2.91 | 10,000 | $29,100.00 | 3,111,091 | SEC Form 4 |
| Green James W | HBIO | Chief Executive Officer | Jun 6 '24 | Buy | $3.07 | 20,000 | $61,400.00 | 3,101,091 | SEC Form 4 |
Latest Harvard Bioscience Inc. News
HBIO Breaking Stock News: Dive into HBIO Ticker-Specific Updates for Smart Investing
Simply Wall St.
15 days ago
Harvard Bioscience Insider Ups Holding During Year
The Telegraph
2 months ago
Italian energy company targets Britain for fleet of 20 mini-nukes
Simply Wall St.
2 months ago
It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend
Simply Wall St.
2 months ago
Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?
Simply Wall St.
2 months ago
Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks
Motley Fool
2 months ago
4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow
Simply Wall St.
2 months ago
Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?
Simply Wall St.
2 months ago
Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)
Compare HBIO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HBIO Harvard Bioscience Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.